Jun Jiang

Dr. Jun Jiang


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 December 2022 in Apoptosis
Verified
Journal Article
Closed access
PDF file
TZTianen Zhou
Tianen Zhou
JMJierong Mo
Jierong Mo
WXWeigan Xu
Weigan Xu
QHQiaohua Hu
Qiaohua Hu
HLHongfeng Liu
Hongfeng Liu
JJJun Jiang
Jun Jiang

1 January 2014 in BioMed Research International
Verified
Journal Article
Open access
PDF file
JJJun Jiang
Jun Jiang
XFXiangshao Fang
Xiangshao Fang
YFYue Fu
Yue Fu
WXWen Xu
Wen Xu
LJLongyuan Jiang
Longyuan Jiang
ZHZitong Huang
Zitong Huang
Postcardiac arrest brain injury significantly contributes to mortality and morbidity in patients suffering from cardiac arrest (CA). Evidence that shows that mitochondrial dysfunction appears to be a key factor in tissue damage after ischemia/reperfusion is accumulating. However, limited data are available regarding the cerebral mitochondrial dysfunction during CA and cardiopulmonary resuscitation (CPR) and its relationship to the alterations of high-energy phosphate. Here, we sought to identify alterations of mitochondrial morphology and oxidative phosphorylation function as well as high-energy phosphates during CA and CPR in a rat model of ventricular fibrillation (VF). We found that impairment of mitochondrial respiration and partial depletion of adenosine triphosphate (ATP) and phosphocreatine (PCr) developed in the cerebral cortex and hippocampus following a prolonged cardiac arrest. Optimal CPR might ameliorate the deranged phosphorus metabolism and preserve mitochondrial function. No obvious ultrastructural abnormalities of mitochondria have been found during CA. We conclude that CA causes cerebral mitochondrial dysfunction along with decay of high-energy phosphates, which would be mitigated with CPR. This study may broaden our understanding of the pathogenic processes underlying global cerebral ischemic injury and provide a potential therapeutic strategy that aimed at preserving cerebral mitochondrial function during CA.

29 November 2025 in National Science Review
Verified
Journal Article
Open access
JLJingyi Liang
Jingyi Liang
HYHaisheng Yu
Haisheng Yu
ZLZhengshi Lin
Zhengshi Lin
XTXi Tang
Xi Tang
ZFZhonghao Fang
Zhonghao Fang
NZNanshan Zhong
Nanshan Zhong
The 2025 chikungunya fever outbreak in Foshan, China rapidly spread from a previously non-endemic area, raising significant public health concerns. This event underscores the need to understand the factors driving viral transmission, host responses and the influence of local environmental changes. The primary objectives of this study were to: (i) characterize the clinical manifestations of chikungunya patients at the initial stage of the outbreak to facilitate concise diagnosis and treatment; (ii) determine the viral genetic factors contributing to the outbreak’s rapid spread; and (iii) investigate the influence of local environmental and climatic conditions on vector mosquito reproduction. We quickly collected and analyzed clinical data from 134 patients hospitalized for the purpose of quarantine at the beginning of the outbreak. While fever, arthralgia and rash are the typical symptom triad of chikungunya fever, we found that they did not always present simultaneously at onset. Arthralgia was the most common presenting symptom. Phylogenetic analysis revealed that the viral strains were highly homologous to those from the Réunion outbreak, suggesting an imported origin. Furthermore, we identified the presence of E1-A226V, E2-I211T and E2-L210Q mutations, which have been previously associated with enhanced transmission by Aedes albopictus. Local climatic conditions during the outbreak period were also found to be favorable for mosquito reproduction. In conclusion, we propose that the Foshan outbreak resulted from a combination of virus importation, a largely immunologically naïve population and a climate conducive to mosquito proliferation. Additionally, our findings suggest that clinicians should maintain vigilance for atypical symptoms to prevent misdiagnosis and missed cases.

1 May 2025 in Digital Health
Verified
Journal Article
Open access
ZLZhiyong Lin
Zhiyong Lin
JDJingyi Deng
Jingyi Deng
SCShiming Chen
Shiming Chen
JHJiawen He
Jiawen He
ZLZhiquan Li
Zhiquan Li
TZTianen Zhou
Tianen Zhou
Objective: Sepsis remains a critical global healthcare challenge with high mortality rates, where traditional diagnostics lack sensitivity and standardized treatments show limited efficacy due to patient variability. While artificial intelligence (AI) has advanced sepsis diagnosis and management, systematic bibliometric analyses are scarce, particularly regarding recent research trends from 2022 to 2025. This study aims to reveal research development patterns and frontier dynamics of AI applications in sepsis diagnosis and management, providing strategic guidance and decision support for researchers, clinicians, and policymakers in this rapidly evolving field. Methods: Web of Science data related to AI in sepsis published from 2005 to 2025 were retrieved. Multidimensional bibliometric and visualization analyses were conducted using VOSviewer, CiteSpace, and Bibliometrix packages. Results: AI applications in sepsis research demonstrated exponential growth since 2016, peaking at 352 publications and 1363 citations in 2024. The United States dominates both publication volume (487 papers) and citation impact (12,984 citations), while China ranks second in output (457 papers) but shows significantly lower impact (3929 citations). Research clustered into six major directions encompassing intelligent prediction, molecular mechanisms, and deep learning early warning systems. Post-2022 analysis revealed emerging keywords including “ARDS (Acute Respiratory Distress Syndrome),” “MIMIC-IV,” and “immune infiltration,” signaling shifts toward multi-omics integration and precision medicine. The most highly cited studies focused on sepsis phenotypic subtyping (776 citations) and AI treatment strategies (619 citations). Conclusion: AI applications in sepsis research are transitioning from algorithm validation toward clinical application, developing in the direction of explainable AI and precision sepsis care. The research trajectory evolves from “proof of concept” toward “ensuring clinical utility.” These findings provide strategic guidance for healthcare systems, highlighting the importance of interpretable models, multi-center validation, and infrastructure development for next-generation precision sepsis management.

30 October 2025 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
XZXuan Zeng
Xuan Zeng
JZJingxin Zhao
Jingxin Zhao
YNYichu Nie
Yichu Nie
JMJierong Mo
Jierong Mo
TZTianen Zhou
Tianen Zhou
JJJun Jiang
Jun Jiang

12 May 2026 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
XZXuan Zeng
Xuan Zeng
YZYuying Zheng
Yuying Zheng
PCPan Chen
Pan Chen
YNYichu Nie
Yichu Nie
JMJierong Mo
Jierong Mo
JJJun Jiang
Jun Jiang